Supported by the following organizations
This is to certify that Dr. Nandini successfully completed and received a passing grade in 1962USRx: Prescription Drug Regulation, Cost, and Access: Current Controversies in Context a course of study offered by HarvardX, an online learning initiative of Harvard University.
Noted by
Aaron Kesselheim
Associate Professor, Director of the Program On Regulation, Therapeutics, And Law, Brigham and Women's Hospital Harvard University
Jonathan Darrow
Assistant Professor of Medicine, Program On Regulation, Therapeutics, And Law, Brigham and Women's Hospital Harvard University
Ameet Sarpatwari
Assistant Professor of Medicine, Assistant Director of the Program On Regulation, Therapeutics, And Law, Brigham and Women's Hospital Harvard University
Jerry Avorn
Professor of Medicine at Harvard Medical School and Emeritus Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics and Co-Director of the Program On Regulation, Therapeutics, And Law Harvard University
-
- Verified Certificate Issued September 10, 2024
- Valid Certificate ID 8705d95bbd784e6e8e012b9c5c9edc84